These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9871769)

  • 1. Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists.
    Cimetière B; Dubuffet T; Muller O; Descombes JJ; Simonet S; Laubie M; Verbeuren TJ; Lavielle G
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1375-80. PubMed ID: 9871769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors.
    Cimetière B; Dubuffet T; Landras C; Descombes JJ; Simonet S; Verbeuren TJ; Lavielle G
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1381-6. PubMed ID: 9871770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S 18886, a new thromboxane (TP)-receptor antagonist is the active isomer of S 18204 in all species, except in the guinea-pig.
    Simonet S; Descombes JJ; Vallez MO; Dubuffet T; Lavielle G; Verbeuren TJ
    Adv Exp Med Biol; 1997; 433():173-6. PubMed ID: 9561128
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and biological activity of 1-phenylsulfonyl-4-phenylsulfonylaminopyrrolidine derivatives as thromboxane a(2) receptor antagonists.
    Marusawa H; Setoi H; Sawada A; Kuroda A; Seki J; Motoyama Y; Tanaka H
    Bioorg Med Chem; 2002 May; 10(5):1399-415. PubMed ID: 11886803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist.
    Osende JI; Shimbo D; Fuster V; Dubar M; Badimon JJ
    J Thromb Haemost; 2004 Mar; 2(3):492-8. PubMed ID: 15009468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel thiazolidine derivatives as thromboxane A2 receptor antagonists.
    Sato M; Kawashima Y; Goto J; Yamane Y; Chiba Y; Jinno S; Satake M; Imanishi T; Iwata C
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):521-9. PubMed ID: 8004696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and pharmacology of 3-substituted sodium azulene-1-sulfonates and related compounds: non-prostanoid thromboxane A2 receptor antagonists.
    Tomiyama T; Yokota M; Wakabayashi S; Kosakai K; Yanagisawa T
    J Med Chem; 1993 Apr; 36(7):791-800. PubMed ID: 8464032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
    Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H; Ito Y
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):765-77. PubMed ID: 8681409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds.
    Main AJ; Goldstein R; Cohen DS; Furness P; Lee W
    J Med Chem; 1992 Nov; 35(23):4362-5. PubMed ID: 1447736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities.
    Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1510-20. PubMed ID: 8795270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 5. Synthesis and evaluation of enantiomers of 8-[[(4-chlorophenyl)sulfonyl]amino]-4-(3-pyridinylalkyl)octanoic acid.
    Bhagwat SS; Gude C; Cohen DS; Dotson R; Mathis J; Lee W; Furness P
    J Med Chem; 1993 Jan; 36(2):205-10. PubMed ID: 8423593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 4. 8-[[(4-Chlorophenyl)sulfonyl]amino]-4-(3-(3-pyridinyl) propyl)octanoic acid and analogs.
    Bhagwat SS; Gude C; Boswell C; Contardo N; Cohen DS; Dotson R; Mathis J; Lee W; Furness P; Zoganas H
    J Med Chem; 1992 Nov; 35(23):4373-83. PubMed ID: 1447738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
    Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives.
    Bühlmayer P; Criscione L; Fuhrer W; Furet P; de Gasparo M; Stutz S; Whitebread S
    J Med Chem; 1991 Oct; 34(10):3105-14. PubMed ID: 1920360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
    Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
    J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of a novel TXA2/PGH2 receptor ligand (S-145) in platelets and vascular and airway smooth muscle.
    Dubé GP; Mais DE; Jakubowski JA; Brune KA; Utterback BG; True TA; Rinkema LE; Kurtz WL
    J Pharmacol Exp Ther; 1992 Aug; 262(2):784-91. PubMed ID: 1386888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.